Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Addict Biol ; 19(5): 874-84, 2014 Sep.
Article in English | MEDLINE | ID: mdl-23763615

ABSTRACT

The current study aimed to elucidate the role of pharmacokinetic (PK) parameters and neurotransmitter efflux in explaining variability in (±) 3, 4-methylenedioxymethamphetamine (MDMA) self-administration in rats. PK profiles of MDMA and its major metabolites were determined after the administration of 1.0 mg/kg MDMA (iv) prior to, and following, the acquisition of MDMA self-administration. Synaptic levels of 5-hydroxytryptamine (5HT) and dopamine (DA) in the nucleus accumbens were measured following administration of MDMA (1.0 and 3.0 mg/kg, iv) using in vivo microdialysis and compared for rats that acquired or failed to acquire MDMA self-administration. Effects of the 5HT neurotoxin, 5,7 dihydroxytryptamine (5, 7-DHT), on the acquisition of MDMA and cocaine self-administration were also determined. In keeping with previous findings, approximately 50% of rats failed to meet a criterion for acquisition of MDMA self-administration. The PK profiles of MDMA and its metabolites did not differ between rats that acquired or failed to acquire MDMA self-administration. MDMA produced more overflow of 5HT than DA. The MDMA-induced 5HT overflow was lower in rats that acquired MDMA self-administration compared with those that did not acquire self-administration. In contrast, MDMA-induced DA overflow was comparable for the two groups. Prior 5,7-DHT lesions reduced tissue levels of 5HT and markedly increased the percentage of rats that acquired MDMA self-administration and also decreased the latency to acquisition of cocaine self-administration. These data suggest that 5HT limits the initial sensitivity to the positively reinforcing effects of MDMA and delays the acquisition of reliable self-administration.


Subject(s)
N-Methyl-3,4-methylenedioxyamphetamine/pharmacokinetics , Serotonin Agents/pharmacology , Serotonin/metabolism , 5,7-Dihydroxytryptamine/pharmacology , Animals , Area Under Curve , Cocaine/administration & dosage , Cocaine/pharmacology , Conditioning, Operant/drug effects , Dopamine/metabolism , Dopamine Uptake Inhibitors/pharmacology , Infusions, Intravenous , Male , Microdialysis/methods , N-Methyl-3,4-methylenedioxyamphetamine/metabolism , Nucleus Accumbens/metabolism , Rats, Sprague-Dawley , Self Administration
2.
Psychopharmacology (Berl) ; 227(2): 355-61, 2013 May.
Article in English | MEDLINE | ID: mdl-23354536

ABSTRACT

A consistent effect of repeated exposure to 3,4 methylenedioxymethamphetamine (MDMA) is a decrease in the tissue levels of serotonin (5-HT). A variety of behavioural and neurochemical tests were conducted to determine whether the tissue deficits were accompanied by an increased sensitivity of the 5-HT1a autoreceptor. Tests were conducted 2 weeks following MDMA exposure (four injections of 10.0 mg/kg, IP, administered at 2-h intervals in a single day). The response to the 5-HT1a agonist, 8-OHDPAT (0.003-0.5 mg/kg, SC), was assessed using lower lip retraction (LLR), hypoactivity, and 5-hydroxytryptophan (5-HTP) accumulation following decarboxylase inhibition. The 8-OHDPAT produced a dose-dependent increase in LLR and hypoactivity, but these effects were comparable for MDMA and saline pretreated groups. MDMA decreased tissue levels of 5-HT and the accumulation of 5-HTP, but these effects were not reflected in the changes in autoreceptor sensitivity. The data suggest that the decrease in tissue levels of 5-HT produced by MDMA is accompanied by a decrease in tryptophan hydroxylase activity but cannot be explained by supersensitivity of the 5-HT1a autoreceptor.


Subject(s)
8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Receptor, Serotonin, 5-HT1A/drug effects , Serotonin Receptor Agonists/pharmacology , 5-Hydroxytryptophan/metabolism , 8-Hydroxy-2-(di-n-propylamino)tetralin/administration & dosage , Animals , Autoreceptors/drug effects , Autoreceptors/metabolism , Behavior, Animal/drug effects , Dose-Response Relationship, Drug , Drug Administration Schedule , Male , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , Rats , Rats, Sprague-Dawley , Receptor, Serotonin, 5-HT1A/metabolism , Serotonin/metabolism , Serotonin Receptor Agonists/administration & dosage , Tryptophan Hydroxylase/metabolism
3.
Addict Biol ; 15(3): 289-98, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20477756

ABSTRACT

Tolerance to the behavioural effects of 3,4-methylenedioxymethamphetamine (MDMA) following high dose exposure has been attributed to alterations in serotonergic systems. The present study aimed to determine whether decreased 5-HT release and/or 5-HT(2A/C) receptor desensitization might play a role in tolerance by measuring the response to selective ligands following MDMA exposure. To this end, the latency to nose poke and emerge from a hide box to an open field arena following administration of various ligands to MDMA pre-treated and control rats was measured. Acute exposure to MDMA (0.0-3.3 mg/kg), the 5-HT releasing stimulant fenfluramine (0.0-2.0 mg/kg) and the 5-HT(2) receptor agonist m-CPP (0.0-1.25 mg/kg) increased nose poke and emergence latency. Following administration of doses that produce 5-HT(2A) receptor-mediated behaviours, the 5-HT(2) receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane failed to alter nose poke and emergence latency, suggesting a limited role of this receptor subtype in these behaviours. Activation of 5-HT(2C) receptors was implicated in the behavioural response to both MDMA and m-CPP since the increased emergence latency was dose-dependently attenuated by pre-treatment with the selective 5-HT(2C) receptor antagonist RS102221 (0.0-1.0 mg/kg). Tolerance to the behavioural effect of MDMA and fenfluramine but not m-CPP was produced by prior exposure to MDMA (10 mg/kg administered at two-hour intervals, total 40 mg/kg), and tissue levels of 5-HT and 5-HIAA were decreased. These findings suggest that tolerance to the increased nose poke and emergence latency produced by MDMA is due to impaired 5-HT release.


Subject(s)
N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Receptor, Serotonin, 5-HT2C/drug effects , Serotonin Agents/pharmacology , Serotonin/metabolism , Amphetamines/pharmacology , Animals , Brain/drug effects , Dose-Response Relationship, Drug , Drug Tolerance , Exploratory Behavior/drug effects , Fenfluramine/pharmacology , Male , Motor Activity/drug effects , Piperazines/pharmacology , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Receptor, Serotonin, 5-HT2A/drug effects , Serotonin Receptor Agonists/pharmacology
4.
Int J Neuropsychopharmacol ; 13(10): 1315-27, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20334725

ABSTRACT

In laboratory animals, exposure to priming injections of 3,4-methylenedioxymethamphetamine (MDMA) produced drug seeking following extinction of MDMA self-administration. This study aimed to evaluate whether the magnitude of drug seeking was related to latency to acquisition of MDMA self-administration and increases in striatal dopamine, as measured by in-vivo microdialysis. Rats were given daily access to MDMA self-administration until they earned a total of 240 infusions (total intake of 165 mg/kg MDMA). Twelve of the 20 rats acquired self-administration within the temporal limits of the study and the latency to meet the criterion ranged from 9 d to 37 d. An experimenter-administered injection of MDMA (10.0 mg/kg i.p.) produced drug seeking in these rats, and the number of responses was significantly higher than responses produced by rats that failed to meet the criterion or by yoked control rats that received the drug passively. For rats that met the criterion, drug seeking was negatively correlated with the number of days to self-administer the criterion number of MDMA infusions and positively correlated with MDMA-produced dopamine in the dorsal striatum. Importantly, MDMA-produced dopamine overflow was greater for the rats that met the criterion. These findings suggest that drug seeking is influenced by initial sensitivity to the reinforcing effects of MDMA and to drug-produced increases in striatal dopamine.


Subject(s)
Drug-Seeking Behavior/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Serotonin Agents/administration & dosage , Serotonin Agents/pharmacology , Animals , Behavior, Animal/drug effects , Corpus Striatum/drug effects , Dopamine/analysis , Dopamine/pharmacology , Dopamine Agents/analysis , Dopamine Agents/pharmacology , Injections , Male , Microdialysis , Models, Animal , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , N-Methyl-3,4-methylenedioxyamphetamine/metabolism , Rats , Rats, Sprague-Dawley , Self Administration , Serotonin Agents/metabolism
5.
Brain Res ; 1317: 137-46, 2010 Mar 04.
Article in English | MEDLINE | ID: mdl-19962371

ABSTRACT

A number of studies have shown that exposure to high doses of methamphetamine (MA) is toxic to central dopamine (DA) and serotonin (5-HT) neurons. In most of those studies, however, high doses of MA were experimenter-administered during a short exposure time. Because contingency is a determinant for many effects of drug exposure, the present objective was to investigate the effects of self-administered MA on tissue monoamine levels following a short (24 hours) or longer (7 days) withdrawal period. As previously reported, a noncontingent "binge" high-dose treatment regimen (4 injections of 10 mg/kg MA administered every 2 hours) produced persistent depletion of cortical 5-HT and striatal DA. Effects of self-administered MA (0.1 mg/kg/infusion) were then determined following a 20-day duration where a yoked design was employed such that some rats received MA contingent on an operant lever press and others received either MA or saline dependent on the responses of the contingent rat. Self-administered MA produced a transient striatal DA depletion with a more persistent increase in DA turnover, indicating the presence of some lasting adaptations. Furthermore, the yoked design revealed that there was no effect of contingency on these parameters.


Subject(s)
Central Nervous System Stimulants/pharmacology , Corpus Striatum/drug effects , Dopamine/metabolism , Frontal Lobe/drug effects , Methamphetamine/pharmacology , Serotonin/metabolism , Animals , Catheterization , Central Nervous System Stimulants/administration & dosage , Corpus Striatum/metabolism , Frontal Lobe/metabolism , Male , Methamphetamine/administration & dosage , Psychomotor Performance , Rats , Rats, Sprague-Dawley , Self Administration , Substance Withdrawal Syndrome , Time Factors
6.
Eur J Neurosci ; 28(9): 1895-910, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18973603

ABSTRACT

The behavioral profile in response to (+/-)-3,4-methylenedioxymethamphetamine (MDMA) is characterized by acute hyperlocomotion that is primarily restricted to the periphery of the open field, whereas behavioral sensitization to MDMA reflects a selective increase in activity in the central zone, suggesting that acute effects and sensitization might rely on neuroadaptations in different systems. This study was thus undertaken to determine whether specific changes in neuronal activation could be correlated with either the acute or sensitized behavioral responses to MDMA. Animals received five daily intraperitoneal (i.p.) injections of saline or MDMA (10 mg/kg). Two days later, animals that received saline were injected with saline or MDMA (5 or 10 mg/kg, i.p.). Animals pretreated with MDMA were injected with saline or MDMA (5 mg/kg, i.p.). Locomotor activity was measured in an open field, and neuronal activation was examined by immunodetection of Fos. Acute MDMA exposure produced a dose-dependent increase in locomotion in the peripheral zone of the open field that was related to an increase in Fos expression in the ventromedial shell of the nucleus accumbens, ventral pallidum, several hypothalamic nuclei and rhomboid thalamic nucleus. Following repeated, intermittent exposure to MDMA, drug-produced hyperactivity became sensitized but, unlike the effect of increasing dose, the increased response was due to increased activity and time spent in the central zone. Furthermore, the sensitized behavioral response was related to changes in Fos expression in the lateral shell of the nucleus accumbens, central nucleus of the amygdala and anteromedial part of the lateral habenula. This study identifies neural substrates that might specifically underlie the sensitized response to MDMA.


Subject(s)
Brain/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Proto-Oncogene Proteins c-fos/drug effects , Amygdala/drug effects , Amygdala/metabolism , Animals , Basal Ganglia/drug effects , Basal Ganglia/metabolism , Behavior, Animal/drug effects , Behavior, Animal/physiology , Brain/anatomy & histology , Brain/metabolism , Brain Mapping , Dose-Response Relationship, Drug , Drug Resistance/drug effects , Drug Resistance/physiology , Habenula/drug effects , Habenula/metabolism , Hallucinogens/pharmacology , Hypothalamus/drug effects , Hypothalamus/metabolism , Immunohistochemistry , Male , Motor Activity/drug effects , Motor Activity/physiology , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Psychomotor Agitation/physiopathology , Rats , Rats, Sprague-Dawley
7.
Behav Pharmacol ; 18(8): 785-90, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17989516

ABSTRACT

The ability of benzylpiperazine (BZP) to substitute for cocaine and to initiate self-administration in drug-naive subjects was assessed to determine whether BZP has abuse liability. Further, the effects of a pretreatment with dopamine D1-like receptor antagonist (SCH23390) were examined to elucidate the mechanisms associated with BZP reward. First, the ability for BZP (0.125, 0.25 and 0.5 mg/kg/infusion) to substitute for cocaine self-administration was assessed, and the acquisition of BZP (0.5 mg/kg/infusion) self-administration by drug-naive and untrained rats was determined during a 15-day period. Subsequently, dose-effect curves for cocaine (0.06, 0.125, 0.25 or 0.5 mg/kg/infusion) and BZP self-administration (0.125, 0.25, 0.5 or 1.0 mg/kg/infusion) and the effect of SCH23390 (0.00 or 0.02 mg/kg) on BZP and cocaine self-administration were examined. BZP substituted for cocaine, and drug-naive rats rapidly acquired BZP self-administration. BZP self-administration was maintained by a more restricted range of doses than was cocaine self-administration, and responding maintained by BZP was sensitive to dopamine antagonism. The present findings indicate that BZP self-administration, like cocaine self-administration, is readily acquired and mediated by dopaminergic mechanisms.


Subject(s)
Illicit Drugs/pharmacology , Piperazines/pharmacology , Animals , Benzazepines/pharmacology , Cocaine/pharmacology , Dose-Response Relationship, Drug , Male , Rats , Rats, Sprague-Dawley , Self Administration
8.
Eur J Neurosci ; 26(4): 1011-25, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17714194

ABSTRACT

The ventral tegmental area (VTA), primary source of the mesocorticolimbic dopaminergic system, is regarded as a critical site for initiation of behavioural sensitization to psychostimulants. The present study was undertaken to identify the neural pathways converging on the VTA that are potentially implicated in this process. Rats were sensitized by a single exposure to amphetamine (5 mg/kg, s.c.). The distribution of VTA-projecting neurons activated by amphetamine was examined by combining retrograde transport of the cholera toxin beta subunit (CTb), injected into the VTA, with immunodetection of Fos. The quantitative analysis of CTb-Fos double labelling demonstrates that amphetamine induced a rapid activation of Fos in a large number of brain areas projecting to the VTA. More than half of the CTb-Fos double-labelled neurons were located in the prefrontal cortex, lateral preoptic area-lateral hypothalamus, pontomesencephalic tegmentum, dorsal raphe nucleus, ventral pallidum and nucleus accumbens. In addition, scattered CTb-Fos double-labelled cells were observed in many other VTA afferent structures, such as claustrum, lateral septum, diagonal band-magnocellular preoptic nucleus, deep mesencephalic nucleus, oral part of pontine reticular nucleus and dorsomedial tegmental area. This suggests that systemic amphetamine activates a wide population of neurons projecting to the VTA that may be important for the modulation of neurobehavioural plasticity produced by this psychostimulant.


Subject(s)
Afferent Pathways/drug effects , Amphetamine/pharmacology , Central Nervous System Stimulants/pharmacology , Ventral Tegmental Area/drug effects , Afferent Pathways/cytology , Animals , Cell Count , Cholera Toxin/pharmacology , Genes, fos/genetics , Immunohistochemistry , Male , Microinjections , Neuronal Plasticity/drug effects , Rats , Rats, Sprague-Dawley , Stimulation, Chemical , Ventral Tegmental Area/cytology
9.
Int J Neuropsychopharmacol ; 8(4): 569-81, 2005 Dec.
Article in English | MEDLINE | ID: mdl-15836801

ABSTRACT

Recent findings have given evidence a role for noradrenergic transmission in the mechanisms underlying behavioural sensitization to psychostimulants. This work was undertaken to investigate the possible role of beta-adrenergic receptors in amphetamine-induced behavioural sensitization in rats. Rats were sensitized by a single administration of amphetamine (1 mg/kg s.c.) and challenged with the same dose 7 d later. The beta(1) /beta(2) -adrenergic receptor antagonists timolol (10 mg/kg i.p.) and nadolol (10 mg/kg i.p.), which respectively cross or do not readily cross the blood-brain barrier, were injected prior to the first or second amphetamine administration. Timolol, but not nadolol, prevented the initiation of behavioural sensitization without interfering with the expression of the sensitized response or the acute locomotor response to amphetamine. Since we found amphetamine-induced fos-activated cells closely associated with dopamine beta-hydroxylase immunoreactive varicosities in the bed nucleus of the stria terminalis (BNST), we investigated the effect of a bilateral micro-injection of timolol into this nucleus. Similarly to systemic administration, intra-BNST timolol (2.5 microg/side) prevented the development of behavioural sensitization. These results suggest that central beta-adrenergic receptors could specifically modulate early neuronal changes leading to the development of behavioural sensitization to psychostimulants, and that the BNST could be an important part of the brain circuitry involved in these long-term neuroadaptations.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Amphetamine/antagonists & inhibitors , Behavior, Animal/drug effects , Central Nervous System Stimulants/antagonists & inhibitors , Septal Nuclei/physiology , Adrenergic beta-Antagonists/administration & dosage , Amphetamine/pharmacology , Animals , Central Nervous System Stimulants/pharmacology , Dopamine beta-Hydroxylase/metabolism , Genes, fos/genetics , Immunohistochemistry , Male , Microinjections , Motor Activity/drug effects , Nadolol/pharmacology , Nerve Fibers/drug effects , Nerve Fibers/enzymology , Rats , Rats, Sprague-Dawley , Timolol/administration & dosage , Timolol/pharmacology
10.
Neuropsychopharmacology ; 30(5): 871-9, 2005 May.
Article in English | MEDLINE | ID: mdl-15637639

ABSTRACT

Studies showing psychostimulant-like effects of exogenous neurotensin (NT) infused into the ventral tegmental area (VTA) prompted us to examine the role in the VTA of the endogenous NT in behavioral sensitization to amphetamine. Rats were sensitized to amphetamine by means of a subcutaneous amphetamine (1 mg/kg) injection, and the same dose was injected 7 days later to evaluate the expression of sensitization. The highly selective NT-receptor antagonist SR 142948A was injected into the VTA prior to the first and/or second amphetamine administration. SR 142948A (5 pmol/side) given before the first amphetamine exposure prevented the induction of behavioral sensitization, but did not alter the acute response to amphetamine. SR 142948A given with the second amphetamine administration did not affect the expression of behavioral sensitization. In contrast to administration into the VTA, intraperitoneal administration of SR 142948A (0.03, 0.1, or 0.3 mg/kg) had no detectable effect on the induction of amphetamine sensitization. These results suggest that activation of VTA NT receptors by endogenous NT may contribute to the neuroadaptations underlying behavioral sensitization to amphetamine.


Subject(s)
Adamantane/analogs & derivatives , Amphetamine/pharmacology , Behavior, Animal/drug effects , Central Nervous System Stimulants/pharmacology , Neurotensin/physiology , Ventral Tegmental Area/physiology , Adamantane/administration & dosage , Adamantane/pharmacology , Animals , Central Nervous System Stimulants/antagonists & inhibitors , Imidazoles/administration & dosage , Imidazoles/pharmacology , Injections, Subcutaneous , Male , Microinjections , Motor Activity/drug effects , Neurotensin/antagonists & inhibitors , Neurotensin/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Neurotensin/antagonists & inhibitors , Ventral Tegmental Area/metabolism
11.
Cell Mol Neurobiol ; 23(4-5): 793-804, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14514032

ABSTRACT

1. Although microdialysis is a widely used approach for in vivo monitoring extracellular neurotransmitter concentrations, it has been previously limited in many cases by its poor temporal resolution. It is clear that when 10-30-min sampling is performed, short-lasting changes in extracellular neurotransmitter concentrations can be overlooked. Such a low sampling rate is necessary when combining microdialysis with the conventional analytical methods like high performance liquid chromatography. 2. Since capillary electrophoresis coupled to laser-induced fluorescence detection (CE-LIFD) allows the detection of attomoles of neurotransmitters, the temporal resolution of microdialysis may be significantly improved: high sampling rates, in the range of 5 s to 1 min, have been already reported by our group and others using CE-LIFD for simultaneously analyzing catecholamines and amino acids in microdialysates. 3. The power of combining microdialyis and CE-LIFD is shown, using examples of physiological and pharmacological studies dealing with the dynamics of in vivo efflux processes and/or interactions between neurotransmitters.


Subject(s)
Brain/metabolism , Catecholamines/analysis , Electrophoresis, Capillary/methods , Excitatory Amino Acids/analysis , Microscopy, Fluorescence/methods , Animals , Catecholamines/metabolism , Electrophoresis, Capillary/instrumentation , Excitatory Amino Acids/metabolism , Lasers , Mice , Microdialysis/instrumentation , Microdialysis/methods , Microscopy, Fluorescence/instrumentation , Rats , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...